The low levels of D6/ACKR2 in primary human thyroid carcinomas and its ability to decrease leukocytes recruitment in vitro and in vivo following its over-expression in anaplastic thyroid carcinoma cells identify a protective role of D6/ACKR2 also in thyroid cancer. Here, ACKR2 is linked to thyroid gland carcinoma.